Literature DB >> 8264645

Developmental stage-specific regulation of atrial natriuretic factor gene transcription in cardiac cells.

S Argentin1, A Ardati, S Tremblay, I Lihrmann, L Robitaille, J Drouin, M Nemer.   

Abstract

Cardiac myocytes undergo a major genetic switch within the first week of postnatal development, when cell division ceases terminally and many cardiac genes are either activated or silenced. We have developed stage-specific cardiocyte cultures to analyze transcriptional control of the rat atrial natriuretic factor (ANF) gene to identify the mechanisms underlying tissue-specific and developmental regulation of this gene in the heart. The first 700 bp of ANF flanking sequences was sufficient for cardiac muscle- and stage-specific expression in both atrial and ventricular myocytes, and a cardiac muscle-specific enhancer was localized between -136 and -700 bp. Deletion of this enhancer markedly reduced promoter activity in cardiac myocytes and derepressed ANF promoter activity in nonexpressing cells. Two distinct domains of the enhancer appeared to contribute differentially to cardiac specificity depending on the differentiation stage of the myocytes. DNase I footprinting of the enhancer domain active in differentiated cells revealed four putative regulatory elements including an A+T-rich region and a CArG element. Deletion mutagenesis and promoter reconstitution assays revealed an important role for the CArG-containing element exclusively in cardiac cells, where its activity was switched on in differentiated myocytes. Transcriptional activity of the ANF-CArG box correlated with the presence of a cardiac- and stage-specific DNA-binding complex which was not recognized by the c-fos serum response element. Thus, the use of this in vitro model system representing stage-specific cardiac development unraveled the presence of different regulatory mechanisms for transcription of the ANF gene during cardiac differentiation and may be useful for studying the regulatory pathways of other genes that undergo switching during cardiac myogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8264645      PMCID: PMC358426          DOI: 10.1128/mcb.14.1.777-790.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  67 in total

1.  A ubiquitous factor (HF-1a) and a distinct muscle factor (HF-1b/MEF-2) form an E-box-independent pathway for cardiac muscle gene expression.

Authors:  S Navankasattusas; H Zhu; A V Garcia; S M Evans; K R Chien
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  Expression cloning of a novel zinc finger protein that binds to the c-fos serum response element.

Authors:  R M Attar; M Z Gilman
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

3.  Characterization of a strong positive cis-acting element of the human beta-myosin heavy chain gene in fetal rat heart cells.

Authors:  I L Flink; J G Edwards; J J Bahl; C C Liew; M Sole; E Morkin
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

4.  Individual stage selector element mutations lead to reciprocal changes in beta- vs. epsilon-globin gene transcription: genetic confirmation of promoter competition during globin gene switching.

Authors:  K P Foley; J D Engel
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

5.  Identification and characterization of a cardiac-specific transcriptional regulatory element in the slow/cardiac troponin C gene.

Authors:  M S Parmacek; A J Vora; T Shen; E Barr; F Jung; J M Leiden
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

6.  A single transcription factor binds to two divergent sequence elements with a common function in cardiac myosin light chain-2 promoter.

Authors:  P Qasba; E Lin; M D Zhou; A Kumar; M A Siddiqui
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

7.  Displacement of BrdUrd-induced YY1 by serum response factor activates skeletal alpha-actin transcription in embryonic myoblasts.

Authors:  T C Lee; Y Shi; R J Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

8.  fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element.

Authors:  K McBride; L Robitaille; S Tremblay; S Argentin; M Nemer
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

9.  Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors.

Authors:  Y T Yu; R E Breitbart; L B Smoot; Y Lee; V Mahdavi; B Nadal-Ginard
Journal:  Genes Dev       Date:  1992-09       Impact factor: 11.361

10.  Functional antagonism between YY1 and the serum response factor.

Authors:  A Gualberto; D LePage; G Pons; S L Mader; K Park; M L Atchison; K Walsh
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

View more
  30 in total

1.  Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression.

Authors:  F Charron; P Paradis; O Bronchain; G Nemer; M Nemer
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

2.  Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice.

Authors:  M Y Tse; J D Watson; I R Sarda; T G Flynn; S C Pang
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

3.  Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload.

Authors:  R von Harsdorf; J G Edwards; Y T Shen; R K Kudej; R Dietz; L A Leinwand; B Nadal-Ginard; S F Vatner
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA.

Authors:  F Charron; G Tsimiklis; M Arcand; L Robitaille; Q Liang; J D Molkentin; S Meloche; M Nemer
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

5.  The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors.

Authors:  D Durocher; F Charron; R Warren; R J Schwartz; M Nemer
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

6.  The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression.

Authors:  Y Lee; T Shioi; H Kasahara; S M Jobe; R J Wiese; B E Markham; S Izumo
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

7.  Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice.

Authors:  N Saadane; L Alpert; L E Chalifour
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

8.  A positive GATA element and a negative vitamin D receptor-like element control atrial chamber-specific expression of a slow myosin heavy-chain gene during cardiac morphogenesis.

Authors:  G F Wang; W Nikovits; M Schleinitz; F E Stockdale
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

9.  CMV enhancer may not be suitable for tissue-specific enhancement of promoters in cancer gene therapy.

Authors:  Jing Jia; Shuzhi Zhang; Zhenyu Jia; Jiang Cao
Journal:  Cancer Gene Ther       Date:  2019-05-27       Impact factor: 5.987

10.  Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptor.

Authors:  S Morin; P Paradis; A Aries; M Nemer
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.